Trial Profile
An open-label study of the efficacy and safety of 5 and 10mg VESIcare (solifenacin succinate) in patients with overactive bladder symptoms VOLT: VESIcare open-label trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Nov 2014
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms VOLT
- Sponsors Astellas Pharma
- 05 Jul 2007 New trial record.